Share on LinkedInShare on LinkedIn

ARTICLE · 19 NOVEMBER 2025

Market Intelligence Thought Leadership Award Winner

Artificial Intelligence And Pharmaceutical Industry: The Transformation In The Technology And Patent System Shaping The Future

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

Artificial intelligence influences every aspect of our lives and creates revolutionary effects in the pharmaceutical industry as well as in many other sectors.

TurkeyIntellectual Property

Artificial intelligence influences every aspect of our lives and creates revolutionary effects in the pharmaceutical industry as well as in many other sectors. From DeepMind's AlphaGo success to Tempus' personalized approaches to cancer treatment, AI-enabled innovations offer not only scientific achievements, but also wide-ranging advantages such as operational efficiency, cost reduction and risk reduction. However, this technological leap also raises critical questions about the traditional processes of the pharmaceutical industry and the patent system.

According to data from the Tufts Drug Development Research Center, it takes about 10 years for a drug to be developed and put on the market, and it costs $ 2.558 billion. In particular, clinical trials account for the majority of this cost, while the success rate is below 10%. These challenges cause the pharmaceutical industry to look for more sustainable and rapid solutions.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from